2017, Number 3
<< Back Next >>
Rev Med Inst Mex Seguro Soc 2017; 55 (3)
Diagnostic approach of erythroderma in the adult
Maldonado-García CA, Orozco-Anahuati AP
Language: Spanish
References: 28
Page: 353-360
PDF size: 301.53 Kb.
ABSTRACT
Erythroderma consists on erythema and scaling that covers
more than 90% of the cutaneous surface. It has multiple
causes and for the most common we can use the acronym
PALM (psoriasis, atopic dermatitis, lymphoproliferative disease
and medication). It is important to diagnose the cause
in order to get a prognosis and a targeted treatment. In 30%
of the cases the cause is not evident and the patient requires
periodic assessment to rule out evolution to a lymphoproliferative
disease. In many cases, erythroderma is a chronic disease
but it can also be a life-threatening dermatologic urgency
that requires hospitalization.
REFERENCES
Li J, Zheng HY. Erythroderma: a clinical and prognostic study. Dermatology. 2012;225(2):154-62.
Groves RW, Kapahi P, Barker JN, Haskard DO, MacDonald DM. Detection of circulating adhesion molecules in erythrodermic skin disease. J Am Acad Dermatol. 1995 Jan;32(1):32-6.
Moy AP, Murali M, Kroshinsky D, Duncan LM, Nazarian RM. Immunologic Overlap of Helper T-Cell Subtypes 17 and 22 in Erythrodermic Psoriasis and Atopic Dermatitis. JAMA Dermatol. 2015 Jul;151(7): 753-60.
Mistry N, Gupta A, Alavi A, Sibbald RG. A review of the diagnosis and management of erythroderma (generalized red skin). Adv Skin Wound Care. 2015 May;28(5):228-36; quiz 237-8.
Yuan XY, Guo JY, Dang YP, Qiao L, Liu W. Erythroderma: A clinical-etiological study of 82 cases. Eur J Dermatol. 2010 May-Jun;20(3):373-7.
Khaled A, Sellami A, Fazaa B, Kharfi M, Zeglaoui F, Kamoun MR. Acquired erythroderma in adults: a clinical and prognostic study. J Eur Acad Dermatol Venereol. 2010 Jul;24(7):781-8.
Zattra E, Belloni-Fortina A, Peserico A, Alaibac M. Erythroderma in the era of biological therapies. Eur J Dermatol. 2012 Mar-Apr;22(2):167-71.
Carter JB, Barnes JA, Niell BL, Nardi V. Case records of the Massachusetts General Hospital. Case 24-2013. A 53-Year-Old Woman with Erythroderma, Pruritus and Lymphadenopathy. N Engl J Med. 2013 Aug 8;369(6):559-69.
Rothe MJ, Bernstein ML, Grant-Kels JM. Life-threatening erythroderma: diagnosing and treating the “red man”. Clin Dermatol. 2005 Mar-Apr;23(2):206-17.
Thestrup-Pedersen K, Halkier-Sørensen L, Søgaard H, Zachariae H. The red man syndrome. Exfoliative dermatitis of unknown etiology: a description and follow-up of 38 patients. J Am Acad Dermatol. 1988 Jun;18(6):1307-12.
Vigliar E, Cozzolino I, Picardi M Peluso AL, Sosa- Fernandez LV, Vetrani A, et al. Lymph node fine needle Cytology in the staging and follow-up of Cutaneous Lymphomas. BMC Cancer. 2014 Jan 6;14:8.
Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood. 2007;110:1713-22.
Vonderheid EC, Bernengo MG, Burg G, Duvic M, Heald P, Laroche L, et al. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol. 2002 Jan;46(1):95-106.
Chitgopeker P, Sahni D. T-Cell Receptor Gene Rearrangement Detection in Suspected Cases of Cutaneous T-Cell Lymphoma. J Invest Dermatol. 2014;134:1-5.
Sterry W, Muche M. Eritrodermia. En: Bolognia JL, Rapini RP, Horn TD, Mascaró JM, Mancini AJ, Salasche SJ, Saurat JH, Stingl G. Dermatología. Philadelphia, EUA. Elsevier Saunders; 2004. pp. 165-74.
Muciño-Bermejo J, Díaz de León-Ponce M, Briones- Vega CG, Guerrero-Hernández A, Sandoval-Ayala OI, Sáenz-Coronado AG. Síndrome de DRESS Reporte de un caso clínico. Rev Med Inst Mex Seguro Soc. 2013;51(3):330-5.
Koh MJ, Tay YK. Stevens-Johnson syndrome and toxic epidermal necrolysis in Asian children. J Am Acad Dermatol. 2010 Jan;62(1):54-60.
Study E, Urbina F, Misad C, Barrios M. Eritrodermia y Dermatomiositis. Actas Dermosifiliogr. 2001;92:524-6. Disponible en http://www.acta sdermo.org/es/eritrodermia- dermatomiositis/articulo -resumen/13020869/
Valdés-González G, Chávez-López M, Gallaga-Gutiérrez A, Reyes-García A. Dermatomiositis-eritrodermia: presentación clínica no asociada a malignidad. Reporte de un caso. Reumatol Clin. 2014;10 (1):48-50.
Mose M, Sommerlund M, Koppelhus U. Severe acute irritant contact dermatitis presenting as exfoliative erythroderm. Contact Dermatitis. 2013 Aug; 69(2):119-21.
Sigurdsson V, Toonstra J, Van Vloten WA. Idiopathic erythroderma: a follow-up study of 28 patients. Dermatology. 1997;194(2):98-101.
Momm F, Pflieger D, Lutterbach J. Paraneoplastic erythroderma in a prostate cancer patient. Strahlenther Onkol. 2002 Jul;178(7):393-5.
Protopsaltis I, Drossou A, Kantsantonis I, Roussos N, Manoludaki K, Arvanitis M, et al. Breast cancer presenting as paraneoplastic erythroderma: an extremely rare case. Case Rep Med. 2014;2014: 351065.
Ge W, Teng BW, Yu DC, Chen G, Zheng LM, Ding YT. Dermatosis as the initial presentation of gastric cancer: two cases. Chin J Cancer Res. 2014 Oct;26 (5):632-8.
Eltawansy SA, Agrawal A, Modi A, Hassanien S, Zhang B, Pei Z, et al. Exfoliative erythroderma as a paraneoplastic presentation of adenocarcinoma of the gallbladder. J Gastrointest Oncol. 2015 Apr;6(2): E26-9.
Andriamanantena D, Boye T, Gervaise A, Vieu C, Splingard B, Dot JM, et al. [An unusual paraneoplastic manifestation in lung cancer: eosinophilic erythroderma]. Rev Pneumol Clin. 2009 Feb;65(1):32-5.
Chong VH, Lim CC. Erythroderma as the first manifestation of colon cancer. South Med J. 2009 Mar; 102(3):334-5.
Tam GF, Kong YL, Tan AS, Tey HL. Causes and features of erythroderma. Ann Acad Med Singapore. 2014 Aug;43(8):391-4.